|
|
||||||||
e Erden
ba KaragülleAnkara University Ibn-i Sina Hospital Samanpazari 06100, Ankara, Turkey
Primary hyperoxaluria is a rare autosomal recessive genetic disorder characterized by excessive synthesis and urinary excretion of oxalic acid. Nephrocalcinosis, which refers to pathologic deposition of calcium oxalate in renal parenchyma, and increased urinary excretion of oxalic acid result in progressive renal failure and nephrolithiasis, respectively [1].
Sonographic findings in nephrocalcinosis caused by hyperoxaluria include increased parenchymal echogenicity of the normal-size kidneys and loss of corticomedullary distinction. Acoustic shadowing arising from the intensely echogenic renal parenchyma may be detected [2]. Conventional radiographs and unenhanced CT scans are also valuable to visualize dense kidneys.
In a 6-year-old boy with a primary hyperoxaluria who underwent peritoneal dialysis, we observed hypoechoic rings around the renal pyramids in addition to the sonographic findings mentioned earlier (Fig. 3A). Unenhanced CT scans show these areas as peripyramidal hypodense ringlike regions (Fig. 3B).
|
|
To our knowledge, there are few reports that include ringlike parenchymal echo changes in renal diseases [3, 4]. Päivänsalo et al. [3] described the hyperechogenic rings in the peripheries of renal medullary pyramids and proved this finding was nonspecific and poorly correlated with the severity of renal disease. However, to our knowledge no reports are available about hypoechoic peripyramidal rings. We think that these areas, which are distributed along the course of the peripyramidal vascularity (interlobar and arcuate vessels), may reflect the spared regions in a diffusely involved renal parenchyma by calcium oxalate crystals.
Further observations are required to clarify diagnostic importance of these areas during the progressive course of the disease.
References
This article has been cited by other articles:
![]() |
S. Aziz, P. W. Callen, F. Vincenti, and R. Hirose Rapidly Developing Nephrocalcinosis in a Patient With End-Stage Liver Disease Who Received a Domino Liver Transplant From a Patient With Known Congenital Oxalosis J. Ultrasound Med., October 1, 2005; 24(10): 1449 - 1452. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |